stars 1 stars 2 stars 3

VLVbio is a Swedish biotechnology company located in Nacka, Stockholm and was established in 2013. We manufacture, R&D, and sell the PEVIVA products. Better tools for more accurate detection of liver damage - that is VLVbio's mission. That is why we present our M30 and M65 ELISA assays, measuring apoptosis and total cell death by quantification of caspase-cleaved and total keratin 18, respectively. That is why we are aiming at setting new industry standards for the identification of liver injury and tumor control. Our products are CE-marked and are used in the fields of hepatology, oncology, and toxicology. The dead cells still count!

VLVbio Questions

The VLVbio annual revenue was $1 million in 2026.

Slavica Brnjic is the Verkställande direktör of VLVbio.

5 people are employed at VLVbio.

VLVbio is based in Nacka, Stockholm.

The NAICS codes for VLVbio are [541713, 541, 5417, 54171, 54].

The SIC codes for VLVbio are [87, 873].

Top VLVbio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users